Platinum-sensitive Recurrent BRCA Wild Type Ovarian Cancer
1 clinical trials · Condition
◉ Watch Platinum-sensitive Recurrent BRCA Wild Type Ovarian Cancer
| Record | Firm | Date |
|---|---|---|
| Olaparib Maintenance With Pembrolizumab & Bevacizumab in BRCA Non-mutated Patients With Platinum-sensitive Recurrent Ovarian Cancer (NCT04361370) | Yonsei University | 2020-10-28 |
Track Platinum-sensitive Recurrent BRCA Wild Type Ovarian Cancer automatically
Every clearance here is in the API, with alerts when new ones post.